Pliant Therapeutics, Inc.

PLRX·NasdaqGS
Compare
0.9860−0.0340 (−3.33%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.0200
Open1.0300
Day range0.98601.0300
52-week range0.97001.9500
Off day high−4.27%
Off 52-week high−49.44%
Volume272.18K
Avg. volume (3M)470.64K
Market cap61.05M
EPS (TTM)-1.50
Forward P/E-0.77
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding61.92M
Short interest—
Earnings dateNov 12, 2026
Analyst target—
Profit margin—

Against its peers

Compare in full ›
PLRX BYSI PYPD PTN ONCY ALXO
Market cap 61.05M 25.31M 101.97M 15.23M 62.06M 174.23M
P/E (TTM) — — — — — —
Forward P/E -0.8 -1.3 -4.1 -4.6 -2.4 -2.3
Price/book 0.4 -0.7 18.9 1.4 -9.7 1.3
Dividend yield — — — — — —
1-year change −31.54% −64.56% +51.80% +18.62% −52.14% −25.88%
Today −3.33% +1.63% −0.99% −0.58% −15.03% +0.80%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Pliant Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
BeyondSpring Inc.BYSI · Biotechnology 25.31M 0.6155 +1.63%
PolyPid Ltd.PYPD · Biotechnology 101.97M 5.02 −0.99%
Palatin Technologies, Inc.PTN · Biotechnology 15.23M 8.55 −0.58%
Oncolytics Biotech Inc.ONCY · Biotechnology 62.06M 0.4733 −15.03%
ALX Oncology Holdings Inc.ALXO · Biotechnology 174.23M 1.2600 +0.80%
Mereo BioPharma Group plcMREO · Biotechnology 50.33M 0.3152 −9.92%
Compugen Ltd.CGEN · Biotechnology 196.08M 2.0700 −2.82%
Rein Therapeutics Inc.RNTX · Biotechnology 67.71M 0.7849 −1.15%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Apollomics, Inc.APLM · Foster City, CA 62.15M 21.32 −0.84%
Xilio Therapeutics, Inc.XLO · Waltham, MA 59.71M 9.08 +0.28%
Oncolytics Biotech Inc.ONCY · San Diego, CA 62.06M 0.4733 −15.03%
Eloxx Pharmaceuticals, Inc.ELOX · Arlington, MA 56.07M 13.89 +1.09%
Fractyl Health, Inc.GUTS · Burlington, MA 58.50M 4.4100 −0.23%
LeonaBio, Inc.LONA · Bothell, WA 58.08M 6.17 +7.22%
iBio, Inc.IBIO · San Diego, CA 58.08M 0.9032 +3.70%
Connect Biopharma Holdings LimitedCNTB · San Diego, CA 57.04M 0.9057 +4.10%

Healthcare companies of a similar market value (61.51M).

Company Mkt cap Price Today
Apollomics, Inc.APLM · Biotechnology 62.15M 21.32 −0.84%
Xilio Therapeutics, Inc.XLO · Biotechnology 59.71M 9.08 +0.28%
Daxor CorporationDXR · Medical Instruments & Supplies 60.16M 10.30 −1.02%
Oncolytics Biotech Inc.ONCY · Biotechnology 62.06M 0.4733 −15.03%
Eloxx Pharmaceuticals, Inc.ELOX · Biotechnology 56.07M 13.89 +1.09%
Fractyl Health, Inc.GUTS · Biotechnology 58.50M 4.4100 −0.23%
LeonaBio, Inc.LONA · Biotechnology 58.08M 6.17 +7.22%
MDxHealth SAMDXH · Diagnostics & Research 57.62M 0.6039 +2.41%

The stocks whose daily moves over the past year went most closely with Pliant Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Bicara Therapeutics Inc.BCAX · Correlation 0.30 1.15B 17.33 −0.97%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All PLRX news ›
The Manila Times·Negative

Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer

Veteran retina commercial leader, who has helped launch BEOVU®, EYLEA® and EYLEA® HD, to lead U.S. commercialization of LYTENAVA™ (bevacizumab-vikg) Mr. DiPasquale brings more than 30 years of commercial leadership experience, including…

Montclair Local·

Baristanet Profile: David Galef

David Galef, often mispronounced. Long a. Near Edgemont Park in Montclair. Watching the turtles and ducklings in season is always a pleasure. 2009. My gosh, has it really been that long? Both, in quantity. It’s hard to imagine writing…

Voice of Healthcare·Positive

Pliant Therapeutics Names David Raben CMO

vohnetwork.com Oncology drug development leader brings over 30 years of academic, clinical and biopharmaceutical expertise to advance Pliant’s targeted therapies.

Markets Daily·Negative

Pliant Therapeutics (NASDAQ:PLRX) Upgraded at Wall Street Zen

Posted by Tristan Rich on Sep 29th, 2026 Wall Street Zen upgraded shares of Pliant Therapeutics (NASDAQ:PLRX – Free Report) from a sell rating to a hold rating in a report released on Saturday morning,Wall Street Zen reports. Separately,…

From articles in the 4Search news index.

In the news

7mentions in 30 days
6with it in the headline
Positivesentiment

Mentioned with

Travere6Amicus Therapeutics5Astrazeneca5Harvard Medical School5Novo Nordisk5Amicus4Biomarin Pharmaceutical Inc.4Board of Directors4

People in the coverage

Eric Dube6Bob Dagher5Bradley5Bradley L. Campbell5Gary Lyons5Allan Reine4

Themes

Appoints6Chief6Medical6Officer6People6Therapeutics6C-Suite5Als4

Most coverage from

  1. manilatimes.net3
  2. markets.businessinsider.com1
  3. themarketsdaily.com1
  4. tradingview.com1
  5. vohnetwork.com1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.